Levodopa (CAS-59-92-7) in dosage/tablet form. The subject product, Levodopa is a medicinal preparation containing Levodopa, as the active ingredient. It is indicated for the treatment of Parkinson’s disease.
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N025968
Carbidopa/Levodopa Tablets. The subject product, Carbidopa/Levodopa Tablets, is a medicinal preparation, in tablet form, containing Carbidopa and Levodopa as active ingredients. Carbidopa/Levodopa Tablets are indicated for the treatment of Parkinson’s disease.
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N248384